» Articles » PMID: 39398428

Synergistically Augmenting Cancer Immunotherapy by Physical Manipulation of Pyroptosis Induction

Overview
Journal Phenomics
Publisher Springer
Date 2024 Oct 14
PMID 39398428
Authors
Affiliations
Soon will be listed here.
Abstract

Pyroptosis is a newly recognized type of programmed cell death mediated by the gasdermin family and caspase. It is characterized by the formation of inflammasomes and the following inflammatory responses. Recent studies have elucidated the value of pyroptosis induction in cancer treatment. The inflammatory cytokines produced during pyroptosis can trigger immune responses to suppress malignancy. Physical approaches for cancer treatment, including radiotherapy, light-based techniques (photodynamic and photothermal therapy), ultrasound-based techniques (sonodynamic therapy and focused ultrasound), and electricity-based techniques (irreversible electroporation and radiofrequency ablation), are effective in clinical application. Recent studies have reported that pyroptosis is involved in the treatment process of physical approaches. Manipulating pyroptosis using physical approaches can be utilized in combating cancer, according to recent studies. Pyroptosis-triggered immunotherapy can be combined with the original anti-tumor methods to achieve a synergistic therapy and improve the therapeutic effect. Studies have also revealed that enhancing pyroptosis may increase the sensitivity of cancer cells to some physical approaches. Herein, we present a comprehensive review of the literature focusing on the associations between pyroptosis and various physical approaches for cancer and its underlying mechanisms. We also discussed the role of pyroptosis-triggered immunotherapy in the treatment process of physical manipulation.

Citing Articles

Integrated proteogenomic characterization of ampullary adenocarcinoma.

Zhang Q, Xu X, Jiang D, Wang Y, Wang H, Zhu J Cell Discov. 2025; 11(1):2.

PMID: 39762212 PMC: 11704194. DOI: 10.1038/s41421-024-00742-4.

References
1.
Munn D, Mellor A . IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance. Trends Immunol. 2016; 37(3):193-207. PMC: 4916957. DOI: 10.1016/j.it.2016.01.002. View

2.
Zanoni I, Tan Y, Gioia M, Broggi A, Ruan J, Shi J . An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells. Science. 2016; 352(6290):1232-6. PMC: 5111085. DOI: 10.1126/science.aaf3036. View

3.
Yang W, Xu H, Liu Q, Liu C, Hu J, Liu P . 5-Aminolevulinic acid hydrochloride loaded microbubbles-mediated sonodynamic therapy in pancreatic cancer cells. Artif Cells Nanomed Biotechnol. 2020; 48(1):1178-1188. DOI: 10.1080/21691401.2020.1813743. View

4.
Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P . Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014; 514(7521):187-92. DOI: 10.1038/nature13683. View

5.
Bertheloot D, Latz E, Franklin B . Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021; 18(5):1106-1121. PMC: 8008022. DOI: 10.1038/s41423-020-00630-3. View